Details.
Partners Andrew D. Cohen and Lachlan S. Campbell-Verduyn will moderate a roundtable discussion titled "Formulation, Delivery, and Route-of-Administration Patents." They will explore how branded and biosimilar companies build, litigate, and defend formulation and delivery patents as core composition claims expire.